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endolysosomes, Wnt signaling causes a
rapid and transient reduction of free
mono-ubiquitin.
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Cellular proteins are degraded in either proteasomes
or lysosomes depending on the types of ubiquitin
chains that covalently modify them. It is not known
whether the choice between these two pathways is
physiologically regulated. The Lys48-polyubiquitin
chain is the major signal directing proteins for
degradation in proteasomes. Here, we report the un-
expected finding that canonical Wnt signaling trans-
locates some K48-linked polyubiquitinated proteins
to the endolysosomal pathway. Proteasomal target
proteins, such as b-catenin, Smad1, and Smad4,
were targeted into endolysosomes in a process
dependent on GSK3 activity. Relocalization was
also dependent on Axin1 and the multivesicular
body (MVB) proteins HRS/Vps27 and Vps4. The
Wnt-induced accumulation of K48-linked polyubiqui-
tinated proteins in endolysosomal organelles was
accompanied by a transient decrease in cellular
levels of free mono-ubiquitin, which may contribute
to Wnt-regulated stabilization of proteins (Wnt/
STOP). We conclude that Wnt redirects Lys48-polyu-
biquitinated proteins that are normally degraded in
proteasomes to endolysosomes.INTRODUCTION
Wnt signaling is intimately linked to the endolysosomal pathway
in the receiving cell. Once bound to the Frizzled and LRP6 co-
receptors, the Wnt ligand is rapidly endocytosed (Blitzer and
Nusse, 2006) into early signalosomes (Bilic et al., 2007) and
then into late endosomal multivesicular bodies (MVBs) (Taelman
et al., 2010; Vinyoles et al., 2014). The activated receptor com-
plex binds cytosolic proteins such as Glycogen Synthase Kinase
3 (GSK3) and Axin1, which become sequestered from the
cytosol inside intraluminal vesicles of MVBs via microautophagy
(Dobrowolski et al., 2012; Vinyoles et al., 2014). For this reason,
canonical Wnt signaling requires the function of the endosomal
sorting complexes required for transport (ESCRT) machinery
(Taelman et al., 2010; Ploper et al., 2015) to sequester GSK3Cand Axin, causing stabilization of its substrate b-catenin in the
cytosol. In the absence of Wnt, phosphorylation of proteins by
GSK3 generates ‘‘phosphodegrons’’ recognized by E3 ubiquitin
ligases such as b-TrCP, triggering polyubiquitination and degra-
dation in proteasomes (Acebron et al., 2014).
GSK3 is a major cellular serine/threonine kinase with many
substrates (Kim et al., 2009). In bioinformatic analyses, about
20% of human proteins were found to contain three or more
consecutive GSK3 sites, raising the possibility that GSK3
phosphodegrons might regulate the degradation of many
cellular proteins (Taelman et al., 2010). Previous studies using
radioactive pulse-chase experiments and biosensors containing
GSK3 sites showed that Wnt signaling, through the inhibition of
GSK3, stabilizes many proteins in addition to b-catenin (Tael-
man et al., 2010; Kong et al., 2013; Acebron et al., 2014).
Because Wnt signaling is highest at the G2/M phase of the
cell cycle, the important proposal was made that the resulting
Wnt-stabilization of proteins (Wnt/STOP) slows down GSK3-
dependent protein degradation in preparation for cell division
(Acebron et al., 2014).
Protein degradation takes place in two different cellular com-
partments, proteasomes and lysosomes, but whether a physio-
logically regulated crosstalk between these protein degradation
pathways exists is unknown (Ciechanover, 2005; Park and
Cuervo, 2013). Lysosomal catabolism includes membrane pro-
teins and endocytosed materials, as well as cytoplasmic do-
mains enveloped by a double membrane via macroautophagy.
Cytosolic proteins containing the Hsc70 recognition sequence
KFERQ-like can also enter the lysosome through chaperone-
mediated autophagy (CMA) (Park and Cuervo, 2013). In addition,
proteins can enter the lysosome through the process known as
microautophagy in which cytosol becomes entrapped inside
the intraluminal vesicles of MVBs. Recently, it has been shown
that some degree of selectivity exists in late endosome microau-
tophagy for proteins containing KFERQ-like sequences (desig-
nated endosomal microautophagy or eMI) (Sahu et al., 2011).
CMA and eMI do not involve ubiquitination, whereas proteaso-
mal degradation and lysosomal targeting of cellular membrane
proteins require ubiquitination.
There are seven lysines in ubiquitin, all of which can participate
in the formation of polyubiquitin (polyUb) chains by forming an
isopeptide bond between the hydroxyl group of Gly76 of a donor
ubiquitin and the ε-amine of one of the lysine residues of an
acceptor ubiquitin (Komander and Rape, 2012). It is thoughtell Reports 11, 1151–1159, May 26, 2015 ª2015 The Authors 1151
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that K48-linked polyubiquitin chains target proteins to proteaso-
mal degradation, whereas monoubiquitination or Lys63-linked
polyubiquitination target membrane proteins to lysosomal
degradation (Nathan et al., 2013). Ubiquitin molecules are
recycled back by proteasome-associated deubiquitinating
enzymes (Lee et al., 2011), and proteins targeted for endolysoso-
mal degradation are thought to be deubiquitinated before
incorporation into MVBs (Piper and Katzmann, 2007). Thus,
ubiquitin recycling plays an important role in regulating cellular
homeostasis.
The starting point for this study was an unexpected observa-
tion: culturedmammalian cells treated withWnt conditionedme-
dium or purified Wnt3a protein showed an increase in levels of
polyubiquitinated proteins in western blots of total cell extracts.
This accumulation was striking in the first few hours of Wnt treat-
ment but was lost at later stages. This increase in polyubiquiti-
nated proteins was counterintuitive because, since Wnt inhibits
GSK3 and consequently phosphodegron formation, the expec-
tation was that total levels of polyUb proteins would be
decreased, in accordance with the stabilization of cellular pro-
teins in pulse-chase experiments (Taelman et al., 2010) and the
decrease in polyubiquitination reported for amultitude of individ-
ual GSK3 target proteins during Wnt/STOP signaling (Acebron
et al., 2014).
We found that Wnt caused accumulation of polyubiquitinated
proteins in the MVB/lysosomal protein degradation pathway,
and that their relocalization to membrane vesicles required the
ESCRTmachinery components HRS/Vps27 (Hepatocyte growth
factor Regulated tyrosine-kinase Substrate) and Vps4 (Vacuolar
protein sorting 4), as well as GSK3 activity. Surprisingly, poly-
ubiquitination via Lys48 was required and sufficient for Wnt-
induced translocation of polyubiquitin into MVBs, while the other
six lysines in ubiquitin were dispensable. We showed that three
soluble GSK3 substrate proteins, Smad1, Smad4, and b-catenin
became translocated to MVBs together with K48-linked polyUb
during Wnt signaling by ESCRT-dependent microautophagy.
Sequestration of K48-linked polyUb proteins in endosomal or-
ganelles was accompanied by a transient decrease in free
mono-ubiquitin, which may contribute to the stabilization of pro-
teins during the first few hours of Wnt/STOP. We conclude that
Wnt signaling causes a switch from proteasomal to lysosomal
degradation of K48-linked polyubiquitinated GSK3 protein
substrates.Figure 1. Lys48-Linked Polyubiquitinated Proteins Accumulate in MVB
(A) Total polyUb (FK1 antibody) accumulation in HEK293T cells after treatment w
(B) Recombinant Wnt3a protein (80 ng/ml) causes rapid accumulation of polyUb
(C) Wnt3a-induced K48-PolyUb accumulation is transient.
(D) The lysosomal inhibitor Chloroquine (CQ) causes stabilization of Wnt3a-induc
(E–E00) K48-polyUb antigens localize to vesicular puncta (arrows) in HeLa cells tre
(F–F00) Total polyUb accumulates in CA-LRP6 vesicles marked by p-LRP6 (arrow
(G–J00) K48-polyUb accumulates in endolysosomes enlarged by CQ treatment in L
(K–K00) Higher-power view of a large CQ-induced MVB (hatched line) showing K
head). Scale bar represents 2 mm.
(L) Accumulation of HA-Ub in CA-LRP6 vesicles requires HRS and Axin. HeLa c
siRNAs. Error bars are SDs.
(M–Q0) The MVB marker Vps4 colocalizes with polyUb accumulation in CA-LRP
represent 10 mm.
See also Figure S1.
CRESULTS AND DISCUSSION
Wnt Signaling Induces Accumulation of PolyUb Proteins
in MVB/Lysosomes
Unexpectedly, we observed that HEK293T cells treated with
Wnt3a for 4 hr displayed an increase in total polyUb content in
western blots using a monoclonal antibody (called FK1) that rec-
ognizes all possible forms of polyubiquitin chains (Figure 1A).
The accumulation of polyUb was most striking between 30 and
120 min after addition of purified Wnt3a protein (Figure 1B).
Use of a K48-polyUb-specific monoclonal antibody showed
that K48-linked polyubiquitinated proteins, which are normally
rapidly degraded in proteasomes, accumulated after 1 hr of
treatment of HEK293T cells with Wnt3a conditioned medium
(Figures 1C, S1A, and S1B). This accumulation was transient,
decreasing after 24 hr of treatment, and becoming undetectable
by 36 hr (Figure 1C). Accumulation of K48-linked polyubiquiti-
nated proteins was not caused by proteasomal inhibition, as
indicated by biosensor reporters of proteasomal activity, which
were not affected by Wnt treatment (Figures S1C and S1D).
Given that Wnt signaling is intimately related to endosomal
trafficking, we next investigated whether the transient accumula-
tion of K48-linked polyUb led to protein degradation in the lyso-
somal pathway. Chloroquine (CQ) is a weak base that causes
lysosome alkalinization and inhibition of acidic hydrolases down-
stream of MVB formation (Dobrowolski et al., 2012). In the pres-
ence of Wnt3a, CQ treatment resulted in a robust accumulation
of K48-linked polyUb after 6 hr (Figure 1D, cf. lanes 2–4). This in-
dicates that the initial acute accumulation of polyUb is followed
by degradation in the lysosomal pathway. Thus, Lys48-linked
polyUb proteins that accumulate after Wnt signaling become
CQ-sensitive lysosomal proteolytic substrates rather than pro-
teasomal targets as is their normal fate.
Then, using immunolocalization, we examined the cellular
compartment in which Wnt-induced polyUb accumulation took
place. Wnt3a treatment caused a significant relocalization of
K48-linked polyUb antigen to vesicle-like puncta in untrans-
fected HeLa cells (Figures 1E–1E00), suggesting translocation
into endolysosomal vesicles. When cells were transfected with
constitutively active LRP6 (CA-LRP6) (generated by deletion
of its extracellular domain; Tamai et al., 2004), total polyubi-
quitinated proteins labeled by the FK1 antibody colocalized
with a phospho-LRP6 (Ser1490) antibody that marks Wnts/Lysosomes during Wnt Signaling
ith control () or Wnt3a (+) conditioned medium (CM) for 4 hr.
.
ed K48-polyUb in HEK293T cells (6-hr treatment).
ated with Wnt3a CM for 4 hr. Scale bars represent 10 mm. Error bars are SDs.
s); arrowhead indicates a non-transfected cell.
-cells treated withWnt3a purified protein (arrows). Scale bars represent 10 mm.
48-polyUb accumulation in puncta inside the MVB limiting membrane (arrow-
ells were transfected with HA-ubiquitin (HA-Ub), CA-LRP6 and the indicated
6 vesicles (arrows) in an HRS, Axin, and Vps4-dependent manner. Scale bars
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signalosomes/MVBs (Figures 1F–F00, arrows). In addition, K48-
linked polyUb colocalized with endogenous GSK3 and lysosome
marker Lamp1 (Figures S1E–S1H00). These results indicate that
the accumulation of polyUb proteins caused by Wnt signaling
takes place in MVB/endolysosomes.
We then investigated whether K48-linked polyUb proteins
could be visualized inside MVB/lysosomal vesicles. We used
the lysosomal inhibitor CQ, which prevents lysosomal degrada-
tion and greatly expands the size of late endosomes/MVBs
(Dobrowolski et al., 2012) so that they can be readily visualized
by DIC light microscopy (Figures 1G–1K). We found that Wnt3a
triggered the accumulation of K48-linked polyUb inside CQ-
enlarged MVBs (arrows in Figures 1I0 and 1J0). At high magnifica-
tion, it could be seen that polyubiquitin was located in puncta
inside the expanded MVBs (arrowhead in Figure 1K0).
Formation of MVBs and microautophagy require ESCRT com-
ponents (Piper and Katzmann, 2007). We found that the relocal-
ization of epitope-tagged HA-Ub in MVBs induced by CA-LRP6
or Wnt3a required both HRS and Axin (Figures 1L and S1L–S1X).
Using EGFP-Vps4, which provides a marker for MVBs, we found
that CA-LRP6-mediated accumulation of polyUb FK1 antigen
strongly colocalized with MVBs (Figures 1N and N0). This coloc-
alization required HRS and Axin function and was inhibited
by a dominant-negative Vps4-EQ mutant (Figure 1O–1Q). Taken
together, the results suggest thatWnt signaling causes the reloc-
alization of polyubiquitinated proteins, including Lys48-linked
polyUb proteasomal targets, into the MVB pathway.
GSK3 Is Required for Wnt-Induced MVB Localization of
Soluble PolyUb Proteins
Given that Wnt regulates GSK3, we asked whether this enzyme
was required for polyUb protein translocation. We found that
Wnt-induced polyUb accumulation was blocked by treatment
with the GSK3 inhibitors BIO, SB-216763, and CHIR99021 (Fig-
ure 2A, cf. lanes 1–3 to 4–6; Figure S2A). This suggested that the
polyUb proteins that accumulate after Wnt treatment may
contain GSK3 phosphodegrons recognized by E3 ubiquitin li-
gases that mediate polyubiquitination. Treatment with the pro-
teasome inhibitor MG132 indicated that the Wnt-stabilized
polyUb represented only a fraction of all proteins degraded in
the proteasome (Figure 2A, lanes 7 and 8). Accumulation of total
polyUb after MG132 proteasomal inhibition was decreased by
treatment with the GSK3 inhibitor BIO (Figure 2B, cf. lanes 2–4
to 6–8). This supports the view that GSK3 phosphodegrons
regulate the degradation of many proteins (Taelman et al.,
2010; Acebron et al., 2014).
To test the relocalization of soluble proteins containing known
Wnt-regulated GSK3 phosphodegrons, we analyzed b-catenin
(MacDonald et al., 2009), Smad1 (Fuentealba et al., 2007), and
Smad4 (Demagny et al., 2014). Phospho-b-catenin and GSK3-
RFP accumulated in vesicles induced by CA-LRP6, as was
also the case for Smad1 or Smad4 phosphorylated by GSK3
(Figures 2C–2H; Figures S2B–B00). In addition, pSmad1GSK3
and pSmad4GSK3 relocalized to EGFP-CA-LRP6 MVBs in micro-
injected Xenopus ectodermal explant cells (Figures 2I, 2J, and
S2C–D00). Thus, mimicking Wnt signaling by CA-LRP6 caused
the endolysosomal relocalization of at least three known GSK3
phosphodegron-containing proteins that are normally soluble.1154 Cell Reports 11, 1151–1159, May 26, 2015 ª2015 The AuthorsThis indicates that CA-LRP6 MVBs are able to incorporate cyto-
solic proteins via microautophagy.
To confirm that polyubiquitination of individual proteins was
increased by Wnt, we carried out biochemical assays in
HEK293T cells cotransfected with HA-ubiquitin, the E3 ligases
b-TrCP or Smurf1, and epitope-tagged b-catenin, Smad1 or
Smad4. Importantly, cells were not treated with proteasome in-
hibitors (a common practice in polyubiquitinylation assays that
prevents rapid degradation in the proteasome, e.g., Acebron
et al., 2014), and lysed in the presence of Triton X-100 and 1%
SDS to solubilize MVBs. Immunoprecipitation studies showed
that the polyubiquitinated fractions of GFP-b-catenin (Figure 2K),
FLAG-Smad1 (Figure 2L), and FLAG-Smad4 (Figure 2M) were
indeed stabilized by Wnt3a treatment for 2–4 hr in the absence
of proteasome inhibitors. However, it is also known that these
three proteins are normally stabilized by Wnt (MacDonald
et al., 2009; Fuentealba et al., 2007; Demagny et al., 2014).
This suggests that the polyubiquitinated fraction that accumu-
lates after Wnt treatment may represent a small part of the total
protein. In the case of b-catenin, the GSK3-phosphorylated form
remains bound to the destruction complex (Li et. al., 2012) and
sequestered in MVBs (Taelman et al., 2010), while newly made
protein accumulates in the cytoplasm and nucleus.
The requirement of GSK3 activity for accumulation of Wnt-
induced polyubiquitinated proteins and the Wnt-induced accu-
mulation of polyubiquitinated Smad4, Smad1, and b-catenin
were counterintuitive because Wnt is expected to inhibit GSK3
phosphodegrons. Taken together, our experiments suggest
that acute Wnt-induced microautophagy of polyubiquitinated
proteins might be confined to protein molecules already phos-
phorylated by GSK3, while the bulk of GSK3-unphosphorylated
proteins remaining in the cytosol, or newly made, are stabilized
via Wnt/STOP as GSK3 is translocated into MVBs and depleted
from the cytosol (Taelman et al., 2010; Vinyoles et al., 2014). In
agreement with the Wnt/STOP model of Acebron et al. (2014),
cell size was increased after 24- or 48-hr treatment with Wnt3a
in HeLa cells (Figures 2N–2P), C32 melanoma cells, and 293T
cells (Figures S3A–S3C), and this cell size increase required
HRS (Figure S3D) and Axin (Figures S3H–S3J).
Lys48-Linked Polyubiquitin Is Required and Sufficient
for MVB Relocalization of Ub during Wnt Signaling
We next investigated whether a specific type of polyUb linkage
was associated with MVB relocalization using ubiquitin point
mutants (Lim et al., 2005). Overexpressed HA-Ub colocalized
with phospho-LRP6 in CA-LRP6 vesicles (Figures 3A–3B0,
arrows). HA-Ub with all seven Lys mutated to Arg cannot form
any type of polyubiquitin chains but can still mono-ubiquitinate
substrates (Lim et al., 2005). This mutant, designated ubiquitin
K0, did not localize in MVBs (Figure 3D). Remarkably, a single
mutation of Lys48 to Arg (ubiquitin K48R), which leaves the other
six Lys residues intact, was sufficient to preventMVB localization
(Figure 3F). Conversely, an ubiquitin mutant with all lysines
mutated to arginine except for Lys48 (ubiquitin K0/K48) accu-
mulated in pLRP6 vesicles (Figure 3H, arrows). Thus, an intact
Lys48 residue of ubiquitin was required and sufficient for
its translocation into CA-LRP6-positive vesicles (Figure 3I).
Moreover, Wnt treatment increased protection of endogenous
Figure 2. GSK3 Is Required for Wnt-Induced Accumulation of PolyUb Proteins and the b-Catenin, Smad1, and Smad4 Phosphodegrons
in MVBs
(A) The GSK3 inhibitor BIO blocked Wnt3a-induced accumulation of polyUb proteins in HEK293T cells.
(B) Inhibiting GSK3 decreasedMG132-induced accumulation of total polyubiquitinated proteins, indicating that GSK3-induced phosphodegrons are responsible
for a sizeable fraction of protein catabolism in HEK293T cells.
(C–D00) Phospho-b-cateninGSK3 colocalized with RFP-GSK3 (arrows) in vesicles induced by CA-LRP6.
(E–F00) Phospho-Smad1GSK3 colocalized with RFP-GSK3 in CA-LRP6 MVBs. Scale bar represents 10 mm.
(G–H00) Phospho-Smad4GSK3 accumulated in the same vesicles as endogenous Axin (arrows) in CA-LRP6-transfected HeLa cells.
(I) Xenopus animal cap explants injected with EGFP-CA-LRP6mRNA and immunostained for endogenous pSmad1GSK3 showing colocalization in vesicles. The
dashed line delineates injected and uninjected cells. Scale bar represents 20 mm.
(J) Endogenous phospho-Smad4GSK3 localizes to EGFP-CA-LRP6-induced vesicles in dissociated Xenopus animal cap cells. Scale bar represents 2 mm.
(K–M) Wnt3a treatment increased HA-Ub levels bound to GFP-b-catenin, FLAG-Smad1, or FLAG-Smad4 after immunoprecipitation. HEK293T cells were co-
transfected with HA-ubiquitin and b-TrCP or Smurf1.
(N–P) Forward scatter area (FSC-A) flow cytometry showing that HeLa cells increase in cell size via Wnt/STOP during 48 hr of treatment.
See also Figure S2.
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Figure 3. Lys48-Linked Polyubiquitination Is Required and Sufficient for Translocation of Ub into Vesicles during Wnt Signaling
(A–B0) Wild-type HA-Ub accumulated in CA-LRP6 vesicles marked by pLRP6S1490 (arrows).
(C–D0) Mutation of all seven lysines (HA-UbK0) prevented relocalization to vesicles.
(E–F0 ) Single mutation of Lys 48 into Arg (HA-UbK48R) blocked endolysosomal localization, indicating that K48-linked polyUb, normally a signal for proteasomal
pathway degradation, is essential for endolysosomal translocation in the presence of Wnt signaling. The p-LRP6 vesicles tended to be smaller in HA-UbK0 and
HA-UbK48R.
(G–H0) Reintroducing K48 into a HA-UbK0 background was sufficient to restore MVB localization.
(I) Quantification of co-localizations shown above, three independent experiments, ***p < 0.001. Error bars are SDs.
(J) Protease protection assay in Digitonin-permeabilized HEK293T cells using anti-Ub antibody to show that Wnt3a protein treatment caused endogenous
polyubiquitinated proteins to become partially protected from Proteinase K (ProK) but only in the absence of Triton X-100 (Tx). Note that a-tubulin, which is not
contained in membrane-bounded organelles, was not protected from Proteinase K digestion.
(K–L00) K48-polyUb and pLRP6 accumulated in vesicles in Xenopus animal cap explants microinjected with EGFP-CA-LRP6mRNA (delineated by dashed lines).
Scale bars represent 20 mm.
See also Figure S3.polyubiquitin from Proteinase K digestion in HEK293T cells per-
meabilized with Digitonin (Figure 3J, lanes 3–6; Figure S3K), con-
firming its relocalization inside membrane-bounded organelles.
In addition, endogenous K48-linked polyUb and microinjected
HA-Ub accumulated in CA-LRP6 MVBs in Xenopus animal cap
cells (Figures 3K–3L; Figures S3L–M00). We conclude that Wnt
signaling causes ubiquitin redistribution from the cytosol to the
endolysosomal pathway specifically through the translocation
of Lys48-linked polyUb proteins, which in the absence of Wnt
would be targeted to proteasomes.
Wnt Causes a Transient Reduction in Free
Mono-Ubiquitin
Ubiquitin homeostasis relies on the recycling of free ubiquitin
from polyubiquitin chains upon proteolysis in both proteasomes
and lysosomes (Lee et al., 2011; Piper and Katzmann, 2007). The1156 Cell Reports 11, 1151–1159, May 26, 2015 ª2015 The Authorsfinding that K48-linked polyUb proteins translocated to the lyso-
somal pathway during Wnt signaling raised an interesting ques-
tion. Could Wnt regulate ubiquitin homeostasis by redistributing
cellular ubiquitin from the cytosol to degradation in the endolyso-
somal pathway? We found that Wnt treatment for 30–120 min
reduced free ubiquitin while simultaneously increasing polyUb
proteins (Figures 4A and 4A0). Using recombinant ubiquitin pro-
tein as a quantification standard, we found that free ubiquitin
levels decreased by 70% after 60–120 min of Wnt treatment
(Figures 4B–4B00). HRS or Axin small interfering RNAs (siRNAs)
prevented this decrease, indicating that MVB formation was
necessary for this Wnt-induced acute reduction of free mono-
ubiquitin in the cytosol (Figure 4C) and polyUb accumulation in
the lysosomal compartment (Figure S3N). However, the reduc-
tion in free ubiquitin levels was restored to normal levels after
3 hr of Wnt treatment (Figures 4D and 4E), perhaps through the
Figure 4. Wnt Signaling Induces a Transient Decrease in Free Ubiquitin Levels
(A) Wnt3a treatment decreased free ubiquitin levels and concomitantly increased polyubiquitinated proteins in HEK293T cells.
(A0) Free ubiquitin levels quantified from five independent experiments using ImageJ. Error bars are SDs.
(B) Wnt3a treatment significantly decreased free ubiquitin levels over a 120-min period; b-catenin accumulation showed that the Wnt treatment was effective.
(B0 ) Standard curve of recombinant pure ubiquitin for quantifications. Error bars are SDs.
(B00) Quantification of the effect of Wnt3a on free mono-ubiquitin, three independent experiments; **p < 0.01. Error bars are SDs.
(C) The decrease in free ubiquitin caused by Wnt3a protein required HRS and Axin.
(D and E) The decrease in free mono-ubiquitin was transient and returned to normal levels after 3 hr of treatment in HEK293T cells; **p < 0.01. Error bars are SDs.
See also Figure S4.feedback regulation of ubiquitin gene expression (Kimura and
Tanaka, 2010).
The transient decrease in free ubiquitin levels should enhance
Wnt responses during the first few hours of Wnt/STOP signaling,
since less ubiquitin is available to target proteins to protea-
somes. The sequestration and degradation of K48-linked polyUb
in the lysosomal compartment would help ensure a rapid switch
from no Wnt to Wnt signaling status. Canonical Wnt signaling is
maintained for many hours, so the marked decrease in free ubiq-
uitin would only contribute to Wnt signaling during the initial
hours, with GSK3 sequestration mediating sustained Wnt
signaling at later stages, leading to the Wnt/STOP increase in
cell size. Experiments involving Tet-inducible ubiquitin over- or
under-expression indicate that transient ubiquitin depletion
may be relevant to Wnt signaling (Figure S4).CConclusions
This study has revealed a novel switch from proteasomal to lyso-
somal protein degradation governed by Wnt signaling. Although
Wnt inhibits the proteasomal degradation of many proteins via
the Wnt/STOP mechanism in which cytosolic proteins remain
unphosphorylated by GSK3 (Acebron et al., 2014), we found
that some proteins polyubiquitinated by K48-linked chains trans-
located together with GSK3 and Axin into MVBs. Inhibition of
lysosomal activity with Chloroquine indicated that these pro-
teins, which would normally be degraded in the proteasome,
are instead degraded in the endolysosomal pathway. Lys63-pol-
yUb or mono-ubiquitin, which target proteins to MVBs, are
recycled back to the cytosol before proteins enter MVBs (Swa-
minathan et al., 1999; Piper and Katzmann, 2007). However, in
the presence of Wnt, K48-linked polyUb is not removed fromell Reports 11, 1151–1159, May 26, 2015 ª2015 The Authors 1157
its targets before entering lysosomes for degradation, leading to
a strong although transient reduction in free ubiquitin levels. The
molecular mechanism by which soluble b-catenin, Smad1, and
Smad4 are translocated from the cytosol to MVBs by microau-
tophagy intoWnt endosomes remains amatter for future studies.
However, the results so far show that it requires GSK3 activity,
Axin, and the ESCRT machinery. In one speculative scenario,
one could imagine that GSK3 might remain bound to its sub-
strates and is carried by Axin bound to oligomerized Dishevelled
(MacDonald et al., 2009) attached to the Wnt receptor complex
in intraluminal vesicles. The three proteins studied here lack
recognizable KFERQ-like motifs, indicating that their vesicular
relocalization is not mediated by the previously described CMA
and eMI mechanisms (Sahu et al., 2011). We conclude that a
crosstalk between the proteasomal and lysosomal protein
degradation pathways exists, and that it is regulated by Wnt
signaling.
EXPERIMENTAL PROCEDURES
Wnt Protein and Antibodies
Purified recombinant Wnt3a protein (PeproTech #315-20) or Wnt3a condi-
tioned medium were used in these experiments, with similar results. Control
and Wnt3a conditioned medium were generated from control L cells (ATCC
#CRL-2648) and L cells stably expressing mouse Wnt3a (ATCC #CRL-2647).
Primary antibodies used were anti-polyUb (FK1) (Enzo #BML-PW8805),
anti-ubiquitin (Santa Cruz Biotechnology #9133), anti-K48-PolyUb (Millipore
#05-1307), anti-b-catenin (Santa Cruz #7199), anti-GAPDH (Cell Signaling
Technology #2118), anti-p-LRP6 S1490 (Cell Signaling Technology #2568),
anti-a-tubulin (Calbiochem #CP06), anti-HA (Sigma-Aldrich #H6908 and
#H9658), anti-p-b-catenin S33/S37/T41 (Cell Signaling Technology #9561),
anti-FLAG (Sigma-Aldrich #F1804), goat anti-Axin1 (R&D Systems #AF3287),
rabbit anti-Axin1 (Cell Signaling Technology #2087), anti-GSK3 (BD Biosci-
ences #610201), anti-Rab7 (Cell Signaling Technology #9367), anti-HRS
(Santa Cruz #30221), anti-Hsp60 (Santa Cruz #1722), anti-p-Smad1GSK3
(Fuentealba et al., 2007), and anti-p-Smad4GSK3 (Demagny et al., 2014).
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